Russell Investments Group
GMAB icon

Russell Investments Group’s Genmab GMAB Stock Holding History

Russell Investments Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3M Buy
883,430
+86,362
+11% +$2.3M 0.02% 664
2026
Q1 		$21.4M Buy
797,068
+86,481
+12% +$2.59M 0.02% 625
2025
Q4 		$21.9M Sell
710,587
-112,152
-14% -$3.5M 0.02% 590
2025
Q3 		$25.2M Sell
822,739
-111,328
-12% -$2.71M 0.03% 538
2025
Q2 		$19.3M Sell
934,067
-146,062
-14% -$3M 0.02% 598
2025
Q1 		$21.1M Buy
1,080,129
+569,345
+111% +$11.9M 0.03% 556
2024
Q4 		$10.7M Buy
510,784
+508,104
+18,959% +$11.2M 0.01% 784
2024
Q3 		$65.3K Buy
2,680
+934
+53% +$25K ﹤0.01% 2738
2024
Q2 		$43.9K Buy
1,746
+807
+86% +$22.9K ﹤0.01% 2792
2024
Q1 		$28.1K Buy
939
+544
+138% +$16K ﹤0.01% 2735
2023
Q4 		$12.6K Sell
395
-1,331
-77% -$41.8K ﹤0.01% 2803
2023
Q3 		$61K Buy
1,726
+83
+5% +$3.16K ﹤0.01% 2720
2023
Q2 		$61.6K Buy
1,643
+1,632
+14,836% +$65.1K ﹤0.01% 2690
2023
Q1 		$415 Buy
+11
New +$423 ﹤0.01% 3168
2022
Q2 		– Sell
-746
Closed -$27K – 2922
2022
Q1 		$27K Sell
746
-7,432
-91% -$255K ﹤0.01% 2665
2021
Q4 		$325K Hold
8,178
– – ﹤0.01% 2580
2021
Q3 		$346K Hold
8,178
– – ﹤0.01% 2601
2021
Q2 		$339K Buy
+8,178
New +$316K ﹤0.01% 2740

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Russell Investments Group's GMAB Position: Q2 2026 in Review

Russell Investments Group increased its Genmab (GMAB) stake by 11% in Q2 2026, buying an estimated $2.3M and bringing the position to 883,430 shares worth $24.3M. The position accounts for 0.02% of the portfolio, ranked #664.

Russell Investments Group first reported a position in GMAB in Q2 2021 and has held it in 18 quarters since. The position peaked at $25.2M in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Russell Investments Group held 883,430 shares of Genmab worth $24.3M as of Q2 2026.
  • Russell Investments Group bought 86,362 Genmab shares in Q2 2026, an estimated $2.3M.
  • Genmab made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #664 holding.
  • Russell Investments Group first reported a position in Genmab in Q2 2021 and has held it in 18 quarters since.
  • Russell Investments Group's Genmab position peaked at $25.2M in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.